Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
McKesson
Mallinckrodt
Express Scripts
Moodys

Last Updated: January 18, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Trafermin

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Trafermin?

Trafermin is an investigational drug.

There have been 6 clinical trials for Trafermin. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2008.

The most common disease conditions in clinical trials are Periodontitis, Ulcer, and Foot Ulcer. The leading clinical trial sponsors are Kaken Pharmaceutical, Olympus Biotech Corporation, and [disabled in preview].

Recent Clinical Trials for Trafermin
TitleSponsorPhase
The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North StudyOlympus Biotech CorporationPhase 3
The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South StudyOlympus Biotech CorporationPhase 3
A Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (Phase 3)Kaken PharmaceuticalPhase 3

See all Trafermin clinical trials

Clinical Trial Summary for Trafermin

Top disease conditions for Trafermin
Top clinical trial sponsors for Trafermin

See all Trafermin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Express Scripts
McKesson
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.